Overview
Thromboembolic disorder is a disorder. There are currently 9 actively recruiting clinical trials.
Treatments & Interventions
Heparin calcium
substance
Anisindione
substance
Papaverine hydrochloride
substance
Potassium warfarin
substance
Heparin sodium
substance
Phenprocoumon
substance
Warfarin sodium
substance
Bishydroxycoumarin
substance
Enoxaparin sodium
substance
Dalteparin sodium
substance
Ardeparin sodium
substance
Argatroban
substance
Enoxaparin
substance
Dalteparin
substance
Danaparoid
substance
Warfarin
substance
Papaverine
substance
Heparin
substance
Ardeparin
substance
Danaparoid sodium
substance
Clinical Trials
Recent Trials
Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support
Research Evidence
Peer-reviewed studies linked via MeSH term "Thromboembolism" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 371039008
- UMLS CUI
- C0040038
- Fully Specified Name
- Thromboembolic disorder (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 20
- Clinical Trials
- 30
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.